CORRECTION: An earlier version of this story said Health Canada had approved several generics for semaglutide. They have received several submissions for approval for ...

Dr Reddy’s Laboratories Ltd. is planning to launch a generic version of Ozempic in March after Novo Nordisk AS's patent for the drug expires. That would make the Indian drugmaker one of the first ...

Vladimir Zakharov explains how DataFrames serve as a vital tool for data-oriented programming in the Java ecosystem. By ...

Sun Pharmaceutical has received approval from the Drugs Controller General of India (DCGI) to manufacture and market a generic version of semaglutide injection, the company said, as it joins domestic ...

Sun Pharmaceutical Industries Ltd said it has received approval from the Drugs Controller General of India (DCGI) to manufacture and market a generic version of semaglutide injection. Semaglutide, a ...

Dr. Reddy's Laboratories (RDY) on Wednesday announced that India’s drug regulator, the Drugs Controller General of India, has issued marketing and manufacturing authorization for a generic version of ...

The companies, which are yet to announce the approval, did not immediately respond to Reuters' request for a comment. Sun Pharma, which is India's largest drugmaker by revenue, on Friday announced ...

Democrats are ahead of Republicans by 6 percentage points on a generic congressional ballot, according to a poll released Thursday. In the Emerson College poll, 48.1 percent of respondents backed a ...

As the midterm election year gets underway, voters are already drawing clear lines between the Democratic and Republican parties on the issues. A new Fox News survey, released Thursday, finds the ...

In the ongoing litigation over Apotex's generic version of GlaxoSmithKline's (GSK) antidepressant paroxetine hydrochloride (Paxil), the US Federal Circuit Appeals Court has reversed the previous ...

Acquisition moves of Sun, Zydus point to Indian pharma’s shift from generics to biopharma A potential Sun Pharma-Organon deal is the clearest signal yet of Indian pharma's urgent, multi-pronged ...

A majority of voters said that Mr. Trump had focused on the wrong priorities and that they disapproved of his handling of top issues, but the president still enjoys strong support from Republicans.